Press & Announcements

Corporate & Clinical News

Official press statements, regulatory approvals, plant facility updates, and medical symposia from G.D. Pharmaceuticals.

Special General Meeting held on proposed IPO
Investor· 15 Jun 2026

Special General Meeting held on proposed IPO

Shareholders convened to approve capital increase, amended articles, and public share issue.

Upcoming Milestones & Events

Coming soon

IPO updates

Coming soon

CSR activities

Coming soon

Health camps

Had a side effect from one of our medicines?

Tell us. Every report helps us keep our products safe. In an emergency, see a doctor first.